Skip to search formSkip to main contentSkip to account menu

Neuropsychiatric Systemic Lupus Erythematosus

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
To define whether anti‐ribosomal P (anti‐P) autoantibodies from patients with neuropsychiatric systemic lupus erythematosus… 
Highly Cited
2014
Highly Cited
2014
The standardized mortality ratio (SMR) for systemic lupus erythematosus (SLE) is three; SMR increases to six in case of renal… 
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To define the cytokine and chemokine profile in cerebrospinal fluid (CSF) from patients with neuropsychiatric systemic… 
Highly Cited
2006
Highly Cited
2006
OBJECTIVE To quantitatively evaluate the diagnostic accuracy of antibodies to ribosomal P proteins (anti-P) for neuropsychiatric… 
Highly Cited
2004
Highly Cited
2004
OBJECTIVE Microtubule-associated protein 2 (MAP-2), a cellular protein restricted to neurons, is important in the control of… 
Review
2002
Review
2002
OBJECTIVE To determine the incidence and prevalence of neuropsychiatric systemic lupus erythematosus (NPSLE) and… 
Highly Cited
2001
Highly Cited
2001
OBJECTIVE To assess the validity of the recently developed American College of Rheumatology (ACR) nomenclature for… 
Highly Cited
2000
Highly Cited
2000
OBJECTIVE The clinical symptoms of neuropsychiatric systemic lupus erythematosus (NPSLE) are usually reversible, but whether the…